BNET Industries

Vaxgen Inc.

(VXGN) is in the Pharma Industry

Market Cap:$19.5M
Last Fiscal Year Sales:$293.0K
  • Public
  • US
Dow Jones Description

VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can be used to make cell culture or microbial biologic products. Learn more...

Number of Employees 3
Contact Information

349 Oyster Point Blvd Ste 200

South San Francisco, California 94080

www.vaxgen.com

(650) 624-1000

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • OXiGENE Reports Third Quarter 2009 Financial Results

    11/09/09 - Merger / Acquisition - View Story

  • Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&D President;...

    10/28/09 - Merger / Acquisition - View Story

  • OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger

    10/18/09 - Joint Venture / Alliance - View Story

  • OXiGENE To Buy VaxGen In A Stock-for-Stock Merger - Quick Facts

    10/15/09 - Merger / Acquisition - View Story

  • Skymark Research Initiates Independent Research Coverage On VaxGen, Inc.

    9/25/09 - Bond / Stock Rating - View Story

News & Analysis

stem-cell and vaxgen inc. - All News and Analysis

advertisement
     VXGN $0.59 -0.06 (-9.23% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 313,067
Shares Outstanding 33.11M
Market Cap 19.5M
Year High 1
Year Low 0.33
Earnings Per Share -0.14
P/E Ratio -4.21
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement